Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (9)

2024

  1. Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus

    Expert Review of Clinical Immunology, Vol. 20, Núm. 4, pp. 359-373

  2. Elucidating the mechanisms and efficacy of antimalarial drugs in systemic lupus erythematosus

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 15, pp. 2047-2060

  3. Routine biomarker profile for the prediction of clinical phenotypes of adult-onset Still's disease using unsupervised clustering algorithm

    International Journal of Rheumatic Diseases, Vol. 27, Núm. 4

2023

  1. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  2. Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies

    Seminars in Arthritis and Rheumatism, Vol. 59

2021

  1. Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century-an observational study from the Lupus-Cruces cohort

    Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 249-257

  2. Burn-out syndrome in spanish internists during the covid-19 outbreak and associated factors: A cross-sectional survey

    BMJ Open, Vol. 11, Núm. 2

2020

  1. Update on antimalarials and systemic lupus erythematosus

    Current opinion in rheumatology, Vol. 32, Núm. 6, pp. 572-582

2019

  1. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus

    Lupus, Vol. 28, Núm. 4, pp. 555-559